{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Zebulon",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "66988",
      "recalling_firm": "GlaxoSmithKline, LLC.",
      "address_1": "1011 North Arendell Ave",
      "address_2": "N/A",
      "postal_code": "27597-1217",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-388-2014",
      "product_description": "Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.",
      "product_quantity": "9,743 cartridges",
      "reason_for_recall": "Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.",
      "recall_initiation_date": "20131106",
      "center_classification_date": "20131224",
      "termination_date": "20140820",
      "report_date": "20140101",
      "code_info": "Lot#: C636242, Exp: 06/15",
      "more_code_info": ""
    }
  ]
}